| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000022895 |
| Receipt No. | R000026387 |
| Official scientific title of the study | Examination of rehabilitation with feedback for patients with hematological cancer |
| Date of disclosure of the study information | 2016/06/27 |
| Last modified on | 2016/06/27 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Examination of rehabilitation with feedback for patients with hematological cancer | |
| Title of the study (Brief title) | Examination of rehabilitation with feedback for patients with hematological cancer | |
| Region |
|
|
| Condition | |||
| Condition | patients with hematological cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | to examine the effect of rehabilitation with feedback forpatients with hematological cancer |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | physical activity |
| Key secondary outcomes | 1.muscle strength/walking ability
2.anxiety/depression(HADS) 3.QOL(EORTC QLQ c-30) |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control:normar rehabilitation
|
|
| Interventions/Control_2 | Interventions:rehabilitation with feedback | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients with hematologic cancer who scheduled for chemotherapy , they has been prescribed physical therapy | |||
| Key exclusion criteria | 1)considered inadequate by the investigator
2)has severe complications 3)has severe dysfunction(cardiac,respiratory,hapatic,renal) 4)has diseases that affects physical activity (Cerebrovascular disease,Orthopedic disease) 5)has dementia |
|||
| Target sample size | 184 | |||
| Research contact person | |
| Name of lead principal investigator | Shun Ishii |
| Organization | Nagasaki University Hospital |
| Division name | Department of Rehabilitation Medicine |
| Address | 1-7-1 Sakamoto, Nagasaki |
| TEL | 095-819-7258 |
| shun331@nagasaki-u.ac.jp | |
| Public contact | |
| Name of contact person | Shun Ishii |
| Organization | Nagasaki University Hospital |
| Division name | Department of Rehabilitation Medicine |
| Address | 1-7-1 Sakamoto, Nagasaki |
| TEL | 095-819-7258 |
| Homepage URL | |
| shun331@nagasaki-u.ac.jp | |
| Sponsor | |
| Institute | Nagasaki University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Japan Society for the Promotion of Science
|
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026387 |